ICON PLC
ICLR
查看详细走势图
182.450USD
-4.130-2.21%
交易中 （美东）报价延迟15分钟
13.93B总市值
24.44市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-2.21%
5天
-1.84%
1月
+12.50%
6月
+25.26%
今年开始到现在
-13.00%
1年
-12.35%
查看详细走势图
TradingKey ICON PLC股票评分
单位: USD 更新时间: 2025-12-12操作建议
ICON PLC当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在生物技术与医疗研究行业排名17/404位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价205.69。中期看，股价处于平稳状态。近一个月，市场表现很强，技术面和基本面综合得分较高，很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
ICON PLC评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
18
位分析师
买入
评级
205.688
目标均价
+12.95%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
ICON PLC亮点
亮点风险
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
行业龙头
公司营业收入处于行业前列，最新年度总收入8.28B美元
利润高增长
公司净利润处于行业前列，最新年度总收入8.28B美元
估值合理
公司最新PE估值25.00，处于3年历史合理位
机构减仓
最新机构持股79.42M股，环比减少11.52%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓，最新持仓市值571.00
活跃度降低
近期活跃度降低，过去20天平均换手率0.06
ICON PLC新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
ICON PLC简介
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
公司代码ICLR
公司ICON PLC
CEOBalfe (Barry Edward)
网址https://www.iconplc.com/
常见问题
ICON PLC(ICLR)的当前股价是多少？
ICON PLC(ICLR)的当前股价是 182.450。
ICON PLC的股票代码是什么？
ICON PLC的股票代码是ICLR。
ICON PLC股票的52周最高点是多少？
ICON PLC股票的52周最高点是228.285。
ICON PLC股票的52周最低点是多少？
ICON PLC股票的52周最低点是125.100。
ICON PLC的市值是多少？
ICON PLC的市值是13.93B。
ICON PLC的净利润是多少？
ICON PLC的净利润为791.47M。
现在ICON PLC(ICLR)的股票是买入、持有还是卖出？
根据分析师评级，ICON PLC(ICLR)的总体评级为买入，目标价格为205.688。
ICON PLC(ICLR)股票的每股收益（EPS TTM）是多少
ICON PLC(ICLR)股票的每股收益（EPS TTM）是7.464。
相关品种
